Sabaa Pharmaceutical's shareholders approve capital raise via bonus issue
Sabaa Pharmaceutical's profit leaps 76% in 2020 initial results
WHO ‘strongly’ against hydroxychloroquine use for COVID-19 prevention
With people at the heart of everything we do, we provide accessible products that make patient’s lives healthier, that physicians prefer for their patients, that employees are proud of, and that investors seek for sustainable returns.
© 2021 - 2024 All Rights Reserved. Designed & Developed By Spark Systems